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ABSTRACT
Objective: Recent data suggest stroke incidence is decreasing over time, but it is unknown
whether incidence is decreasing in women and men to the same extent.
Methods: Within our population of 1.3 million, all incident strokes among residents$20 years old
were ascertained at all hospitals during July 1993–June 1994 and calendar years 1999, 2005,
and 2010. A sampling scheme was used to ascertain out-of-hospital cases. Sex-specific inci-
dence rates per 100,000 among black and white participants, age- and race-adjusted, were
standardized to the 2000 US Census population. Trends over time by sex were compared;
a Bonferroni correction was applied for multiple comparisons.
Results: Over the 4 study periods, there were 7,710 incident strokes; 57.2% (n 5 4,412) were
women. Women were older than men (mean 6 SE 72.4 6 0.34 vs 68.2 6 0.32, p , 0.001).
Incidence of all strokes decreased over time in men (263 [confidence interval 246–281] to 192
[179–205], p , 0.001) but not in women (217 [205–230] to 198 [187–210], p 5 0.15). Similar
sex differences were seen for ischemic stroke (men, 238 [223–257] to 165 [153–177], p ,
0.01; women, 193 [181–205] to 173 [162–184], p 5 0.09). Incidence of all strokes and of
ischemic strokes was similar between women and men in 2010. Incidence of intracerebral hem-
orrhage and subarachnoid hemorrhage were stable over time in both sexes.
Conclusions: Decreases in stroke incidence over time are driven by a decrease in ischemic stroke
in men. Contrary to previous study periods, stroke incidence rates were similar by sex in 2010.
Future research is needed to understand why the decrease in ischemic stroke incidence is more
pronounced in men. Neurology® 2017;89:990–996
GLOSSARY
ARIC 5 Atherosclerosis Risk in Communities; GCNKSS 5 Greater Cincinnati/Northern Kentucky Stroke Study; ICD-9 5
International Classification of Diseases–9; ICH 5 intracerebral hemorrhage; mRS 5 modified Rankin Scale; SAH 5 sub-
arachnoid hemorrhage.
To accurately assess the public health effects of stroke and to effectively reduce stroke mortality,
it is crucial to understand epidemiologic differences between women and men. Because of an
increased lifetime risk of stroke as well as worse functional outcomes following stroke,1–4 women
may be affected disproportionately by stroke; for these reasons, epidemiologic differences by sex
are especially important to investigate.
Though previous literature has consistently shown that age-adjusted stroke risk is higher in
men,5–7 women face a higher lifetime risk of stroke compared with men due to longer life
expectancies. Overall stroke incidence has been decreasing over time,8 but whether there are
sex differences in temporal trends of stroke incidence is less clear. The fact that stroke has
declined to the fifth leading cause of death for men but remains the fourth leading cause of
death for women suggests that stroke incidence may be decreasing faster in men compared with
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women.9,10 In addition, some reports indicate
that case-fatality may be decreasing more in
men than in women.5,11
Recent decreases in stroke incidence are
likely a result of improved control of risk fac-
tors, including hypertension, diabetes, dyslipi-
demia, and smoking.11,12 Given known sex
differences in risk factor profiles, understand-
ing temporal patterns in the prevalence of
stroke risk factors by sex is necessary to reduce
stroke incidence and mortality in both sexes.
Recently, more attention has been paid to
stroke prevention in women as demonstrated
by published guidelines for approaches to
managing stroke risk factors that are more
prevalent in or unique to women.13 It is
unknown whether sex-specific prevention
strategies are being implemented routinely or
if they are effective.
Our primary study objective was to deter-
mine whether stroke incidence has been
decreasing over the past 16 years to the same
extent in women compared with men. Our
second objective was to investigate 30-day
stroke case-fatality rates over time by sex. A
third objective was to compare the prevalence
of stroke risk factors and related medication
use between women and men over time as
potential contributors to sex differences in
stroke incidence.
METHODS Study setting/population. We used data from
the Greater Cincinnati/Northern Kentucky Stroke Study
(GCNKSS), a population-based study of a largely biracial pop-
ulation of approximately 1.3 million people who reside in
a 5-county region of Southwest Ohio/Northern Kentucky. All
first-ever strokes among adult ($20 years old) residents of the
region were ascertained during 4 study periods: July 1993 to June
1994, and calendar years 1999, 2005, and 2010. All cases pre-
senting to the acute care hospitals in the study region (14–17
hospitals depending on the study period) were included and
identified using ICD-9 codes 430–436. Cases not identified
through hospital records were ascertained through records from
the region’s public health clinics, hospital-based outpatient clin-
ics, and coroners’ offices, as well as through sampling of primary
care offices and nursing homes in the study region, according to
a predefined scheme. All cases of stroke during the study periods
were verified by study physicians. Cases of TIA were excluded.
Methods for case screening and verification remained consistent
across all 4 time periods. Further details regarding the GCNKSS
methodology have been previously published.14 This study was
approved by the institutional review board at each participating
hospital during each study period.
Stroke incidence. Sex-specific incidence rates per 100,000,
adjusted for age and race, and standardized to the 2000 US census
population were calculated for overall stroke and for the
individual stroke subtypes ischemic stroke, intracerebral hemor-
rhage (ICH), and subarachnoid hemorrhage (SAH) during each
study period. For our main study outcome, trends in incidence
rates by sex were compared over time and specifically between
1993/1994 and 2010.
Case-fatality. Case-fatality was defined as death from any cause
within 30 days of incident stroke. Deaths were verified using
a combination of death certificate data from the Ohio and Ken-
tucky Departments of Vital Statistics and the national Social
Security Death Index. If death was reported during the index hos-
pitalization, the state mortality sources or Social Security Death
Index was used for corroboration. Sex-specific case-fatality rates,
adjusted for age and race, were calculated for all stroke subtypes
and for specific stroke subtypes (ischemic stroke, ICH, SAH) for
each of the 4 study periods.
Stroke risk factors. Data on the prevalence of stroke risk factors
and medication use were taken from our general population sur-
vey (a random-digit dial survey) conducted during each of 4 study
periods: 1995, 2000, 2005, and 2011. The survey sampling
design, using predefined quotas, is such that survey participants’
characteristics (sex, race, age) are representative of the GCNKSS
ischemic stroke study population. Detailed methodology
regarding the survey has been published previously.15,16 Survey
respondents were asked to report whether they were ever diag-
nosed with common stroke risk factors and whether they were
currently taking medications to control certain conditions. We
examined the proportion of women vs men who reported having
the risk factors hypertension, hypercholesterolemia, diabetes,
heart disease, prior stroke/TIA, and current smoking and who
reported using antihypertensive medications, lipid-lowering
agents, and aspirin. Data on warfarin use were available only in
2011.
Statistical approach. Demographics. Demographic character-
istics by sex were compared over time in years, using a general lin-
ear model. A Tukey-Kramer adjustment was used to control for
multiple comparisons across years.
Stroke incidence. Incidence rates with 95% confidence inter-
vals were estimated using the age-, race-, and sex-specific raw
counts from the GCNKSS as the numerator. The denominator
was the population age-, race-, and sex-specific estimate for the
appropriate study year for the 5-county area. This rate was
adjusted to the 2000 US census.17 The primary comparison was
the change in incidence between 1993/1994 and 2010. We also
compared sex-specific incidence rates between adjacent study
periods (1993/1994 vs 1999, 1999 vs 2005, and 2005 vs 2010).
Due to these 4 multiple comparisons, p values were adjusted
using a Bonferroni correction. To compare the trend over time
between women and men, a general linear model was used with
an offset of the log of the population size.
Case-fatality. General linear models adjusted for age, race,
and year were used to examine changes over time and the differ-
ence between women and men; the model assumed a Poisson dis-
tribution with a log link. A Tukey-Kramer adjustment for
multiple comparisons was used when examining differences
between women and men for case-fatality at each timepoint.
Risk factors. Generalized linear models were used to assess
overall trends over the 4 study periods by sex for each risk factor,
medication, or demographic variable, and to compare women vs
men at each timepoint; Tukey-Kramer adjustments were used to
control for the multiple comparisons. Interaction terms of sex by
year were included.
For all analyses, testing was 2-sided, and p , 0.05 was con-
sidered significant (an adjusted p value when noted due to
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multiple testing). Data analyses were performed using SAS, Ver-
sion 9.4 (SAS Institute, Cary, NC). Further details regarding
statistical methods are in the supplemental data at Neurology.org.
RESULTS Table 1 shows baseline characteristics by
sex. Across the 4 study periods, there were 7,710
incident strokes, 4,412 (57.2%) of which occurred
in women. On average, women were older in each
study period; the overall mean age for women was
71.6 (SD 15.1) vs 67.3 (SD 14.1) for men (p ,
0.001). Overall, the proportion of black patients
was similar by sex (women, n 5 880, 19.9% vs
men, n 5 602, 18.3%, p 5 0.91). Overall, a smaller
proportion of women had prestroke modified Rankin
Scale (mRS) scores of 0 or 1 than men (n 5 2,429,
55.1% vs n 5 2,311, 70.1%, p , 0.0001).
The decrease in incidence of all strokes (table 2,
figure) over time was significant only in men. There
was a decrease in incidence between 1993/1994 and
2010 for men (263 per 100,000 in 1993/1994 to 192
per 100,000 in 2010, p, 0.001) but not for women
(217 per 100,000 in 1993/1994 to 198 per 100,000
in 2010, p 5 0.15). The year by sex interaction had
a p value of 0.10. In 2010, incidence of all strokes was
not different between women and men (p 5 0.50).
The decrease in incidence of ischemic stroke over
time was significant only in men. There was a decrease
in incidence between 1993/1994 and 2010 in men
(238 per 100,000 in 1993/1994 to 165 per 100,000
in 2010, p , 0.001) but not in women (193 per
100,000 in 1993/1994 to 173 per 100,000 in
2010, p 5 0.09). The p value was 0.07 for the year
by sex interaction. There was no difference in inci-
dence of ischemic stroke between women and men in
2010 (p 5 0.31). ICH and SAH incidence did not
decrease over time between first and last study periods
in women (p 5 0.99 and p 5 0.70, respectively) or
men (p 5 0.46 and p 5 0.16, respectively).
Table 1 Greater Cincinnati/Northern Kentucky Stroke Study baseline characteristics of stroke cases by sex and time period
Overall 1993/1994 1999 2005 2010
Women Men Women Men Women Men Women Men Women Men
No. 4,412 3,298 1,104 812 1,166 829 1,041 817 1,101 840
Age, ya 72.4 (0.34) 68.2 (0.32) 72.7 (0.36) 69.2 (0.41) 73.0 (0.34) 68.1 (0.40) 70.3 (0.36) 65.8 (0.41) 70.4 (0.37) 66.0 (0.42)
Black race 880
(19.1%)
602
(17.3%)
206
(18.7%)
138
(17.0%)
210
(18.0%)
134
(16.2%)
228
(21.9%)
157
(19.2%)
236
(21.4%)
173
(20.6%)
Baseline mRS
0 or 1b
2,429
(57.6%)
2,311
(72.5%)
697
(66.8%)
603
(79.1%)
700
(61.9%)
607
(74.9%)
545
(52.4%)
561
(69.2%)
487
(44.4%)
540
(64.6%)
Abbreviation: mRS 5 modified Rankin Scale.
No. represents the unweighted number of incident cases for all strokes. p Values for sex-specific trends over time were ,0.0001 for age, race, and mRS
for both women and men. Data presented as mean (standard error) or n (weighted percentage). Tukey-Kramer adjustment used for multiple comparisons. No
missing observations for sex, age, or race. Missing data for mRS: n 5 137 in 1993/1994, n 5 78 in 1999, n 5 11 in 2005, n 5 7 in 2010.
a Female . male in each time period, p , 0.0001.
b Female , male in each time period, p , 0.0001.
Table 2 Greater Cincinnati/Northern Kentucky Stroke Study stroke incidence rates per 100,000 (95%confidence interval) over time by sex,
adjusted to the 2000 US population
Type of stroke
1993/1994 1999 2005 2010
Women Men Women Men Women Men Women Men
All 217 (205–230) 263a (246–281) 241 (228–254) 269 (251–286) 189 (178–201) 228 (214–244) 198 (187–210) 192a (179–205)
[n 5 1,104] [n 5 812] [n 5 1,166] [n 5 829] [n 5 1,041] [n 5 817] [n 5 1,101] [n 5 840]
Ischemic 193 (181–205) 238a (223–257) 207 (195–219) 249 (232–266) 168 (157–178) 207 (193–221) 173 (162–184) 165a (153–177)
[n 5 974] [n 5 719] [n 5 1,004] [n 5 746] [n 5 925] [n 5 728] [n 5 946] [n 5 719]
ICH 25 (21–30) 31 (25–37) 33 (28–38) 35 (29–41) 30 (25–34) 37 (31–43) 25 (21–30) 34 (28–39)
[n 5 140] [n 5 110] [n 5 167] [n 5 131] [n 5 172] [n 5 146] [n 5 158] [n 5 145]
SAH 11 (8–14) 8 (5–11) 14 (11–17) 6 (3–9) 12 (9–15) 5 (3–8) 10 (8–13) 5 (3–7)
[n 5 58] [n 5 27] [n 5 71] [n 5 24] [n 5 67] [n 5 24] [n 5 59] [n 5 25]
Abbreviations: ICH 5 intracerebral hemorrhage; SAH 5 subarachnoid hemorrhage.
Incidence rates (95% confidence interval) are per 100,000 and adjusted by age and race. The unweighted number of strokes are shown in square brackets
as [n5 ]. The incidence rates and the unweighted numbers shown are type-specific and “all” includes any type of stroke, thus the total of individual incidence
rates for ischemic, ICH, and SAH will not add up to the rate for “all.”
a Adjusted p value , 0.05 for comparison between 1993/1994 and 2010 using Bonferroni.
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When adjacent study periods were compared,
rates of all stroke for 1993/1994 vs 1999 were similar
for both women (p 5 0.06) and men (p 5 0.64).
Although rates for women decreased between 1999
and 2005 (p , 0.0001), they were not different
between 2005 and 2010 (p 5 0.27). Rates for men,
however, decreased between 1999 and 2005 (p 5
0.003) and between 2005 and 2010 (p 5 0.002).
Similar patterns were observed with ischemic stroke.
Rates for women did not change for 1993/1994 vs
1999 (p 5 0.57), decreased for 1999 vs 2005 (p ,
0.0001), and did not change for 2005 vs 2010 (p 5
0.48), whereas the rates for men did not change for
1993/1994 vs 1999 (p 5 0.35) but decreased for
both 1999 vs 2005 (p 5 0.001) and 2005 vs 2010
(p, 0.0001). When trends over time were compared
between women and men, sex by time interaction
terms had p values of 0.11, 0.07, 0.79, and 0.59 for
all stroke, ischemic stroke, ICH, and SAH,
respectively.
There were no significant differences in case-
fatality over time (table 3) in either sex or between
women and men within each study period for all
strokes, for ischemic strokes, or for SAH.
Table 4 displays risk factor prevalence and related
medication use by sex over time. In all study periods,
significantly fewer women reported completing at least
12 years of education compared with men. A higher
proportion of women reported having a diagnosis of
hypertension and taking antihypertensive medications
compared with men in 2000, 2005, and 2011. A lower
proportion of women reported aspirin use in 2000 and
2005. The use of antihypertensive medications, lipid-
lowering agents, and aspirin increased over time in both
women and men. For trends in risk factor prevalence
over time, the prevalence of hypertension, diabetes
Figure Ischemic stroke incidence rates, trends over time by sex
Incidence rates and 95% confidence intervals. Incidence rates were adjusted by age and race. p Value for comparisons
made between 1993/1994 and 2010 was ,0.001 in men and 0.09 in women. Bonferroni corrections were made for
multiple comparisons.
Table 3 Greater Cincinnati/Northern Kentucky Stroke Study 30-day case-fatality rates (adjusted for age and race) after incident stroke, by
sex and stroke subtype
1993/94 1999 2005 2010
Women Men Women Men Women Men Women Men
All
strokes
13.1% [n 5 179] 12.4% [n 5 119] 12.1% [n 5 198] 12.7% [n 5 133] 14.1% [n 5 176] 12.6% [n 5 119] 14.4% [n 5 193] 13.0% [n 5 109]
Ischemic 9.1% [n 5 129] 9.2% [n 5 85] 7.6% [n 5 130] 8.1% [n 5 88] 9.0% [n 5 117] 8.0% [n 5 73] 9.5% [n 5 124] 8.5% [n 5 66]
ICH 32.6% [n 5 51] 33.9% [n 5 38] 31.9% [n 5 70] 39.8%a [n 5 53] 38.1%b [n 5 76] 40.8%b [n 5 62] 37.9%a [n 5 69] 36.7%a,c [n 5 54]
SAH 35.7% [n 5 25] 28.8% [n 5 9] 33.6% [n 5 24] 32.3% [n 5 7] 27.6% [n 5 20] 19.6% [n 5 5] 26.8% [n 5 17] 16.1% [n 5 4]
Abbreviations: ICH 5 intracerebral hemorrhage; SAH 5 subarachnoid hemorrhage.
Tukey-Kramer adjustment used for multiple comparisons. Percentages are weighted and adjusted for age and race. Unweighted number of deaths are
shown in square brackets as [n 5 ].
a For ICH: p , 0.0001 for sex-specific comparisons between 1993/1994 and specified year.
b For ICH: p , 0.01 for sex-specific comparisons between 1993/1994 and specified year.
c For ICH: p , 0.01 for sex-specific comparisons between 1999 and specified year.
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mellitus, and hyperlipidemia increased, and current
smoking decreased; these trends were significant in both
women and men across the 4 study periods. Use of
warfarin was 6.4% in women and 7.1% inmen in 2011.
DISCUSSION Data in recent years have shown
a decrease in mortality from stroke, thought to be largely
due to decreasing stroke incidence over time.5,8,11 Our
study findings, however, show that the overall decrease in
stroke incidence over time is primarily driven by
a decrease in ischemic stroke in men. Like previous data,7
our findings show that age-adjusted stroke incidence was
higher in men between 1993 and 2005; however, in
2010, stroke incidence rates were similar between the
sexes, a critical and novel finding of this study. The
similar incidence rates in women compared with men in
2010 may be a result of a more substantial decrease in
stroke incidence in men than women over time. Our
findings are in line with recent data from the Centers for
Disease Control and Prevention showing that stroke has
decreased to the fifth leading cause of death for men yet
remains the fourth leading cause of death for women.9,10
Though case-fatality is another possible contributor to
the difference in stroke mortality between women and
men, our findings suggest that there is no significant
difference in case-fatality by sex and that there have been
few significant temporal changes in stroke case-fatality
either in men or in women.
Our findings conflict to some degree with other
studies, though these differences may be due largely
to study design. Carandang et al.5 used the Framing-
ham cohort and found no difference by sex but only
looked through 2004, while our study includes data
through 2010. The Atherosclerosis Risk in Commu-
nities (ARIC) study, a prospective cohort study,
included data through 2011 and found no sex differ-
ences over time; however, it is important to note that
both the Framingham and the ARIC study are cohort
studies and did not investigate all strokes in a defined
geographic population as ours did.5,8 Cohort studies
are also prone to other biases including participation
bias. A third study, the Oxford Vascular Study, was
designed as a population-based study but was limited
by power and only looked at incidence rates through
2004.12 Interestingly, though, their results indicate
that the decrease in stroke incidence in men was more
dramatic than the decrease in women.12
Contributors to the differential decrease of stroke
incidence in men compared with women are unclear.
Contrary to our initial hypothesis, our analysis of sur-
vey data shows that common stroke risk factors have
been increasing in both sexes in our population. This
Table 4 Greater Cincinnati/Northern Kentucky Stroke Study medication use, risk factor prevalence, and demographics over time, by sex
1995 (n 5 1,880) 2000 (n 5 2,173) 2005 (n 5 2,156) 2011 (n 5 2,036)
Overall trend p
valuea
Women Men Women Men Women Men Women Men Women Men
No. 1,121 759 1,334 839 1,328 828 1,244 792
Medication use, n (%)
Antihypertensive 413 (36.8) 236 (31.1) 561b (42.0) 298 (35.5) 621c (46.8) 319 (38.5) 691c (55.6) 377 (47.6) ,0.0001 ,0.0001
Lipid-lowering 104 (9.3) 80 (10.5) 283 (21.2) 153 (18.2) 376 (28.3) 257 (31.0) 474 (38.1) 298 (37.6) ,0.0001 ,0.0001
Aspirin 254b (22.7) 228 (30.0) 427d (32.0) 341 (40.6) 456d (34.3) 364 (44.0) 677 (54.4) 461 (58.2) ,0.0001 ,0.0001
Risk factor prevalence, n (%)
Hypertension 506 (45.1) 312 (41.1) 625 (46.8) 358 (42.7) 684 (51.5) 379 (45.8) 744 (59.8) 431 (54.4) ,0.0001 ,0.0001
Diabetes 146 (13.0) 109 (14.4) 215 (16.1) 138 (16.4) 244 (18.4) 125 (15.1) 286 (23.0) 173 (21.8) ,0.0001 0.0005
Dyslipidemia 363 (32.4) 244 (32.2) 514 (38.5) 308 (36.7) 564 (42.5) 372 (44.9) 624 (50.2) 388 (49.0) ,0.0001 ,0.0001
Current smoker 235 (21.0) 167 (22.0) 265 (19.9) 168 (20.0) 267 (20.1) 165 (19.9) 187 (15.0) 140 (17.7) 0.0005 0.04
Heart disease 94 (8.4) 91 (12.0) 104d (7.8) 103 (12.3) 101 (7.6) 91 (11.0) 98 (7.9) 91 (11.5) 0.63 0.58
Prior stroke or TIA 71 (6.3) 58 (7.6) 95 (7.1) 61 (7.3) 121 (9.1) 57 (6.9) 112 (9.0) 74 (9.3) 0.004 0.27
Demographics
Age, y, mean (SD) 64.4 (16.3) 60.6 (15.7) 62.1 (17.9) 58.8 (16.2) 62.6 (17.8) 59.9 (16.6) 67.7 (14.7) 64.2 (14.6) ,0.0001 0.002
Black race 319 (28.5) 188 (24.8) 393d (29.5) 161 (19.2) 356d (26.8) 173 (20.9) 344 (27.6) 200 (25.2) 0.35 0.59
Education >12 y 377d (33.6) 376 (49.5) 590d (44.2) 502 (59.8) 654d (49.2%) 510 (61.6) 652d (52.4) 517 (65.2) ,0.0001 ,0.0001
Tukey-Kramer adjustment used for multiple comparisons.
a Pertain to sex-specific trends over time.
bWomen vs men, p , 0.05.
cWomen vs men, p , 0.01.
dWomen vs men, p , 0.001.
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contrasts with recent findings from the Framingham
study, which reported a decrease in hypertension
and hyperlipidemia over time.18 The discrepancies
between the Framingham study and our study
include a significant difference in the racial and socio-
economic distribution of the study population and
differences in how vascular risk factors were defined.
The Satizabal study operationalized hypertension and
hyperlipidemia using numeric physical examination
and laboratory values, whereas our study used
a patient-reported history of risk factors. In addition,
the sample for the GCNKSS survey was designed to
represent the population at risk for stroke according
to age, race, and sex, which may affect risk factor
prevalence. It is unknown whether our findings of
increasing prevalence of stroke risk factors are due
to a diagnosis bias or if disease prevalence has truly
increased. We also do not know whether risk factors
such as hypertension are being controlled equally
effectively in women and men; previous data indicate
that even when treated with antihypertensive medi-
cations, women are less likely to meet blood pressure
targets.19,20 Another possibility is that the same degree
of risk factor control is associated with a different level
of risk in men compared to women, as appears to be
the case for diabetes in women.21 It will be important
to conduct further research on the driving factors
behind the decreasing stroke incidence in men, as
such factors could potentially be applied to women
as well. We also analyzed self-reported use of medi-
cations that help control stroke risk factors and found
that both men and women have increased their use of
antihypertensives, lipid-lowering medications, and
aspirin over time. Though aspirin use doubled over
time in women, fewer women than men reported
aspirin use overall, a potentially concerning finding
given knowledge that aspirin is recommended for
women (but not men) 55–79 years old for primary
prevention of ischemic stroke.22 This is an opportu-
nity for further research.
Another potential contributor to the greater
decrease in stroke incidence in men compared with
women is a change in our study population over time.
The proportion of patients who were functionally
independent as indicated by a baseline mRS of 0 or
1 decreased significantly over time and appears to
have decreased more in women than men. Reasons
for this are unclear, though it may be driven by the
functional status of older women. In addition, we
observed a significant decrease in the mean age at
time of stroke over time in both women and men
and a consistent difference between sexes at each
timepoint; women were always older at stroke onset.
If mRS is considered a surrogate for other measures of
health including comorbidities or frailty, our data
may indicate that our study population in 2010,
especially women, were in worse health and at higher
risk for stroke than in other study periods.
Our finding that the incidence of hemorrhagic
stroke did not change significantly over time is consis-
tent with other literature.23 Reasons for this are
unclear, but the protective effects of increased use
of antihypertensive medications might be attenuated
by the increased use of antithrombotics, leading to no
net change in incidence.24,25
Our use of self-reported survey data to measure
stroke risk factors may lead to an underestimate of
the true prevalence of stroke risk factors; such an under-
estimate may limit our understanding of how stroke risk
factors over time influence differential changes in stroke
incidence by sex. It is also possible that stroke risk fac-
tors such as hypertension and diabetes are less well-
controlled in women or that women have an underlying
longer duration of such diseases, but our self-reported
survey does not capture these data. Our survey instru-
ment does not include items about risk factors unique
to or more prevalent in women including atrial fibrilla-
tion, exogenous hormones, and migraine that could be
changing over time and affecting stroke incidence in
women. Other risk factors for which we could not
account but that may affect stroke incidence in women
more than men include depression and psychosocial
stressors. Finally, we do not have data on the sex and
demographic characteristics of participants who
declined to participate in the survey.
Further discussion regarding changes of stroke
incidence between adjacent study periods and of the
contribution of factors such as education level of par-
ticipants and changes in dietary supplements can be
found in the supplemental data.
We found that the decrease in overall stroke inci-
dence over time seems to be driven primarily by
a decrease in incidence of ischemic stroke in men and
that the change in stroke incidence in women over
the same period was not significant. These changes
may have led to the nearly equal rate of stroke in women
andmen in 2010. Going forward, we plan to extend our
analyses to confirm whether this pattern continues
beyond 2010. Our current findings, in combination
with our group’s past work showing that stroke inci-
dence is not decreasing to the same extent in black
compared with white participants,14 demonstrate that
targeted stroke prevention efforts may be needed to
effectively decrease stroke incidence (and thus mortality
from stroke) across all demographic groups.
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